# Integra LifeSciences Corporation clinical trials: 82 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 82 trials with Integra LifeSciences Corporation as lead sponsor, 4 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Integra LifeSciences Corporation: 82 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/integra-lifesciences-corporation

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 82
- Recruiting or not yet: 4
- Read on: November 19, 2026

## Trials

The 25 newest of 82, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 4, 2026 | NCT07805798 | Urinary Bladder Matrix (UBM) Registry | Integra LifeSciences Corporation | Observational | Not yet recruiting | Tissue Repair, Soft Tissue Reconstruction, Wound Management, Pressure Ulcer (PU), Necrotizing Soft Tissue Infection... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07805798) |
| July 17, 2025 | NCT07071298 | AERA Pediatrics Registry | Integra LifeSciences Corporation | Observational | Recruiting | Dysfunction of Eustachian Tube | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07071298) |
| January 7, 2025 | NCT06760611 | Tissue Quality of Integra vs. BTM Treated Burns | Integra LifeSciences Corporation | Observational | Withdrawn | Burn Injury, Burn Scar, Burn Wounds - Partial Thickness (2nd Degree), Skin Grafting | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06760611) |
| October 8, 2024 | NCT06629506 | MicroMatrix® Flex in Tunneling Wounds | Integra LifeSciences Corporation | Not applicable | Completed | Pressure Injury, Venous Ulcer, Necrotizing Soft Tissue Infection, Diabetic Ulcers, Draining Wound | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06629506) |
| June 11, 2024 | NCT06453187 | A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers | Integra LifeSciences Corporation | Not applicable | Enrolling by invitation | Diabetic Foot Ulcer, Venous Leg Ulcer | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06453187) |
| March 7, 2024 | NCT06297187 | Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study | Integra LifeSciences Corporation | Observational | Completed | Vulvar Intraepithelial Neoplasia, Condylomata Acuminata | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06297187) |
| February 26, 2024 | NCT06276543 | Bactiseal Catheter Safety Registry Study | Integra LifeSciences Corporation | Observational | Recruiting | Hydrocephalus | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06276543) |
| September 13, 2023 | NCT06034652 | T-GENVIH-003 LTFU (Long Term Follow Up) Study | Integra LifeSciences Corporation | Observational | Completed | Hernia, Hernia, Ventral, Pathological Conditions, Anatomical, Hernia, Abdominal | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06034652) |
| December 15, 2022 | NCT05652296 | External Ventricular Drainage Post-Market Clinical Follow-up Registry | Integra LifeSciences Corporation | Observational | Completed | Cerebrospinal; Disorder | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05652296) |
| November 9, 2022 | NCT05610267 | Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair | Integra LifeSciences Corporation | Observational | Completed | Ventral Hernia | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05610267) |
| May 31, 2022 | NCT05397106 | Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve | Integra LifeSciences Corporation | Observational | Active not recruiting | Hydrocephalus, Hydrocephalus in Children, NPH (Normal Pressure Hydrocephalus), IIH - Idiopathic Intracranial... | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05397106) |
| April 25, 2022 | NCT05343143 | NeuraGen 3D Pilot Study | Integra LifeSciences Corporation | Not applicable | Terminated | Digital Nerve Injury | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05343143) |
| April 21, 2022 | NCT05339594 | REINVENT Registry (Registry of the Nerve Gap Repair From Integra) | Integra LifeSciences Corporation | Observational | Terminated | Peripheral Nerve Injuries | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05339594) |
| January 10, 2022 | NCT05182177 | The SurgiMend PRS Retrospective Study | Integra LifeSciences Corporation | Observational | Completed | Reconstructive Surgical Procedures | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05182177) |
| November 9, 2021 | NCT05113381 | The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of Intraventricular Hemorrhage... | Integra LifeSciences Corporation | Not applicable | Completed | Intraventricular Hemorrhage, Subarachnoid Hemorrhage | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05113381) |
| August 27, 2021 | NCT05024656 | AmnioExcel® Plus vs SOC in the Management of Diabetic Foot Ulcers | Integra LifeSciences Corporation | Not applicable | Withdrawn | Diabetic Foot Ulcer | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05024656) |
| June 11, 2021 | NCT04923867 | Suturable DuraGen™ PMCF Study | Integra LifeSciences Corporation | Observational | Completed | Cerebrospinal Fluid Leak | 106 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04923867) |
| August 3, 2020 | NCT04496414 | Bactiseal Catheter Safety Registry in China | Integra LifeSciences Corporation | Observational | Completed | Hydrocephalus | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04496414) |
| July 31, 2020 | NCT04494295 | The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation | Integra LifeSciences Corporation | Observational | Recruiting | Supratentorial Hemorrhage | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04494295) |
| March 9, 2020 | NCT04300075 | The CUSA Clarity Bone Tip Study | Integra LifeSciences Corporation | Observational | Withdrawn | Cranial Skull Base Bone Removal | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04300075) |
| March 6, 2020 | NCT04298268 | The CUSA Clarity Soft Tissue Removal Study | Integra LifeSciences Corporation | Observational | Completed | Benign, Malignant Tumors or Other Soft Tissue Removal, Nephrectomy or Partial Nephrectomy With Parenchyma Removal | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04298268) |
| February 26, 2020 | NCT04285489 | A Study on the Safety of Hakim Programmable Shunt System | Integra LifeSciences Corporation | Observational | Completed | Hydrocephalus | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04285489) |
| December 20, 2019 | NCT04207229 | CERTAS Programmable Valve Registry | Integra LifeSciences Corporation | Observational | Completed | Hydrocephalus, NPH (Normal Pressure Hydrocephalus), IIH - Idiopathic Intracranial Hypertension | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04207229) |
| August 1, 2019 | NCT04041037 | The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series | Integra LifeSciences Corporation | Observational | Terminated | Pilonidal Disease | 2 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04041037) |
| January 25, 2019 | NCT03816202 | Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF) | Integra LifeSciences Corporation | Observational | Completed | Carotid Artery Stenosis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03816202) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 2/3 | 1 |
| Phase 3 | 5 |
| Phase 4 | 1 |
| Not applicable | 42 |
| Observational | 33 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 49 |
| Terminated | 21 |
| Withdrawn | 6 |
| Recruiting | 3 |
| Enrolling by invitation | 1 |
| Active not recruiting | 1 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetic Foot | 13 |
| Otitis Media | 8 |
| Sinusitis | 6 |
| Hydrocephalus | 5 |
| Wounds and Injuries | 5 |
| Foot Ulcer | 4 |
| Varicose Ulcer | 3 |
| Pressure Ulcer | 3 |
| Diabetes Mellitus | 3 |
| Hernia, Ventral | 2 |
| Hydrocephalus, Normal Pressure | 2 |
| Pseudotumor Cerebri | 2 |
| Otitis Media with Effusion | 2 |
| Tissue Adhesions | 2 |
| Infections | 2 |
| Burns | 2 |
| Cerebrospinal Fluid Leak | 2 |
| Hernia | 2 |
| Diabetes Complications | 2 |
| Ulcer | 2 |
| Condylomata Acuminata | 1 |
| Rhinitis | 1 |
| Carotid Stenosis | 1 |
| Lung Diseases | 1 |
| Brain Neoplasms | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Brewing supply stores in the United States](https://specstream.ai/data/businesses/brewing-supply-stores/united-states)
- [Cancer treatment centers in the United States](https://specstream.ai/data/businesses/cancer-treatment-centers/united-states)
- [Chinese restaurants in the United States](https://specstream.ai/data/businesses/chinese-restaurants/united-states)
- [Computer training centers in the United States](https://specstream.ai/data/businesses/computer-training-centers/united-states)
- [Customs brokers in the United States](https://specstream.ai/data/businesses/customs-brokers/united-states)
- [Dominican restaurants in the United States](https://specstream.ai/data/businesses/dominican-restaurants/united-states)
